Symbols / YCBD $0.87 -4.67% cbdMD, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • ASE
YCBD Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. T. Ronan Kennedy
Exch · Country ASE · United States
Market Cap 9.10M
Enterprise Value 6.31M
Income -3.71M
Sales 19.09M
FCF (ttm) -6.11M
Book/sh 0.89
Cash/sh 0.32
Employees 42
Insider 10d —
IPO Nov 17, 2017
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 1.45
Forward P/E -0.97
PEG —
P/S 0.48
P/B 0.97
P/C —
EV/EBITDA -4.90
EV/Sales 0.33
Quick Ratio 1.62
Current Ratio 2.94
Debt/Eq 6.58
LT Debt/Eq —
EPS (ttm) 0.60
EPS next Y -0.89
EPS Growth —
Revenue Growth -1.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-02-17
Earnings (prior) 2026-02-17
ROA -12.66%
ROE -43.36%
ROIC —
Gross Margin 60.59%
Oper. Margin -5.71%
Profit Margin -12.25%
Shs Outstand 10.50M
Shs Float 10.20M
Insider Own 10.68%
Instit Own 7.65%
Short Float 3.28%
Short Ratio 0.79
Short Interest 322.35K
52W High 2.56
vs 52W High -66.11%
52W Low 0.47
vs 52W Low 84.57%
Beta 2.10
Impl. Vol. —
Rel Volume 0.82
Avg Volume 1.60M
Volume 1.31M
Target (mean) $2.00
Tgt Median $2.00
Tgt Low $2.00
Tgt High $2.00
# Analysts 1
Recom None
Prev Close $0.91
Price $0.87
Change -4.67%
About

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.00
Mean price target
2. Current target
$0.87
Latest analyst target
3. DCF / Fair value
$-10.48
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.87
Low
$2.00
High
$2.00
Mean
$2.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-08-20 main Maxim Group Buy → Buy $2
2025-05-22 main Maxim Group Buy → Buy $3
2023-10-05 init Maxim Group — → Buy $3
News
RSS: Latest YCBD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-14 SELLERS BAKARI T Director — 1,572 $0.00 $0
2026-04-14 RAINES WILLIAM F III Director — 1,572 $0.00 $0
2026-04-14 STEPHEN SCOTT G Director — 1,572 $0.00 $0
2026-04-14 SWIFT SIBYL NICHOLE Director — 1,572 $0.00 $0
2026-04-14 ROE KEVIN CHARLES Director — 1,572 $0.00 $0
2026-04-14 PORTER JEFFREY H Director — 1,572 $0.00 $0
2025-12-17 CROSNOE CLARK R. Beneficial Owner of more than 10% of a Class of Security — 550,701 $2.31 $1,276,842
2025-11-28 KENNEDY THOMAS RONAN Chief Executive Officer — 445,000 $0.00 $0
2025-05-16 SELLERS BAKARI T Director — 1,572 $0.00 $0
2025-05-16 RAINES WILLIAM F III Director — 1,572 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
19.19
-1.50%
19.48
-19.35%
24.16
-31.77%
35.40
Operating Revenue
19.19
-3.67%
19.92
-20.48%
25.05
-32.51%
37.12
Cost Of Revenue
7.22
-3.53%
7.49
-18.43%
9.18
-29.76%
13.07
Reconciled Cost Of Revenue
6.55
-3.87%
6.82
-15.34%
8.05
-32.51%
11.93
Gross Profit
11.97
-0.23%
12.00
-19.91%
14.98
-32.95%
22.34
Operating Expense
14.13
-7.71%
15.31
-36.85%
24.25
-38.84%
39.65
Research And Development
0.03
-13.24%
0.04
-77.45%
0.17
-72.68%
0.63
Selling General And Administration
11.43
-9.42%
12.62
-30.42%
18.14
-41.94%
31.25
Selling And Marketing Expense
4.43
+5.97%
4.18
-39.84%
6.95
-55.00%
15.44
General And Administrative Expense
7.00
-17.04%
8.44
-24.57%
11.19
-29.19%
15.81
Salaries And Wages
5.06
-9.08%
5.57
-28.55%
7.79
-44.13%
13.94
Other Gand A
1.22
-20.26%
1.53
-16.66%
1.83
-1.59%
1.86
Other Operating Expenses
1.54
+2.53%
1.50
-63.71%
4.13
-30.37%
5.93
Total Expenses
21.35
-6.34%
22.80
-31.79%
33.42
-36.59%
52.71
Operating Income
-2.16
+34.77%
-3.32
+64.23%
-9.27
+46.46%
-17.31
Total Operating Income As Reported
-2.16
+34.77%
-3.32
+85.26%
-22.49
+71.27%
-78.27
EBITDA
-0.37
+75.47%
-1.49
+76.42%
-6.34
+55.78%
-14.34
Normalized EBITDA
-0.37
+76.64%
-1.57
-121.23%
7.39
-80.89%
38.69
Reconciled Depreciation
1.80
-1.35%
1.82
-37.82%
2.93
-1.44%
2.97
EBIT
-2.16
+34.77%
-3.32
+64.23%
-9.27
+46.46%
-17.31
Total Unusual Items
0.00
-100.00%
0.07
+100.54%
-13.73
+74.10%
-53.03
Total Unusual Items Excluding Goodwill
0.00
-100.00%
0.07
+100.54%
-13.73
+74.10%
-53.03
Special Income Charges
0.00
-100.00%
0.07
+100.57%
-13.03
+75.41%
-53.00
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
0.00
-100.00%
13.22
-78.31%
60.96
Restructuring And Mergern Acquisition
0.00
+100.00%
-0.07
+59.83%
-0.19
+97.64%
-7.87
Net Income
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Pretax Income
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Net Non Operating Interest Income Expense
0.03
+216.27%
-0.03
-146.32%
0.06
+292.11%
0.02
Interest Expense Non Operating
—
—
—
—
Net Interest Income
0.03
+216.27%
-0.03
-146.32%
0.06
+292.11%
0.02
Interest Expense
—
—
—
—
Interest Income Non Operating
—
—
0.06
+292.11%
0.02
Interest Income
—
—
0.06
+292.11%
0.02
Other Income Expense
0.09
+124.60%
-0.36
+97.41%
-13.73
+73.98%
-52.79
Other Non Operating Income Expenses
0.09
+120.33%
-0.43
—
0.24
Gain On Sale Of Security
—
—
-0.70
-1998.95%
-0.03
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Net Income From Continuing Operation Net Minority Interest
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Net Income From Continuing And Discontinued Operation
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Net Income Continuous Operations
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Net Income Discontinuous Operations
—
—
—
—
Normalized Income
-2.04
+45.93%
-3.77
+58.99%
-9.20
+46.03%
-17.06
Net Income Common Stockholders
-4.38
+43.21%
-7.70
+71.40%
-26.94
+63.64%
-74.09
Diluted EPS
-1.09
+92.37%
-14.29
+86.59%
-106.56
+76.13%
-446.40
Basic EPS
-1.09
+92.37%
-14.29
+86.59%
-106.56
+76.13%
-446.40
Basic Average Shares
4.02
+646.22%
0.54
+113.25%
0.25
+52.31%
0.17
Diluted Average Shares
4.02
+646.22%
0.54
+113.25%
0.25
+52.31%
0.17
Diluted NI Availto Com Stockholders
-4.38
+43.21%
-7.70
+71.40%
-26.94
+63.64%
-74.09
Amortization
0.77
+9.69%
0.70
-50.05%
1.40
+57.90%
0.88
Amortization Of Intangibles Income Statement
0.77
+9.69%
0.70
-50.05%
1.40
+57.90%
0.88
Depreciation Amortization Depletion Income Statement
1.13
-2.06%
1.15
-36.15%
1.80
-1.78%
1.83
Depreciation And Amortization In Income Statement
1.13
-2.06%
1.15
-36.15%
1.80
-1.78%
1.83
Depreciation Income Statement
0.36
-20.18%
0.45
+11.88%
0.40
-57.40%
0.95
Gain On Sale Of PPE
—
—
0.00
-100.00%
0.09
Preferred Stock Dividends
2.33
-41.70%
4.00
+0.05%
4.00
0.00%
4.00
Rent And Landing Fees
0.73
-46.26%
1.35
-14.05%
1.57
—
Rent Expense Supplemental
0.73
-46.26%
1.35
-14.05%
1.57
—
Total Other Finance Cost
-0.03
-216.27%
0.03
+146.32%
-0.06
—
Line Item Trend 2023-09-30
Total Assets
16.20
Current Assets
8.07
Cash Cash Equivalents And Short Term Investments
1.80
Cash And Cash Equivalents
1.80
Other Short Term Investments
0.00
Receivables
1.22
Accounts Receivable
1.22
Gross Accounts Receivable
1.26
Allowance For Doubtful Accounts Receivable
-0.04
Inventory
4.05
Raw Materials
1.40
Finished Goods
2.78
Prepaid Assets
0.25
Other Current Assets
0.75
Total Non Current Assets
8.13
Net PPE
4.21
Gross PPE
5.66
Accumulated Depreciation
-1.46
Properties
0.00
Machinery Furniture Equipment
1.40
Construction In Progress
0.14
Other Properties
3.64
Leases
0.49
Goodwill And Other Intangible Assets
3.22
Goodwill
—
Other Intangible Assets
3.22
Investments And Advances
0.70
Other Non Current Assets
—
Total Liabilities Net Minority Interest
7.16
Current Liabilities
4.67
Payables And Accrued Expenses
3.21
Payables
2.57
Accounts Payable
1.91
Dividends Payable
0.67
Current Accrued Expenses
0.63
Current Debt And Capital Lease Obligation
1.28
Current Debt
0.00
Other Current Borrowings
—
Current Capital Lease Obligation
1.28
Current Deferred Liabilities
0.19
Current Deferred Revenue
0.19
Total Non Current Liabilities Net Minority Interest
2.49
Long Term Debt And Capital Lease Obligation
2.40
Long Term Capital Lease Obligation
2.40
Non Current Deferred Liabilities
—
Non Current Deferred Taxes Liabilities
—
Other Non Current Liabilities
0.09
Stockholders Equity
9.03
Common Stock Equity
9.03
Capital Stock
0.01
Common Stock
0.00
Preferred Stock
0.01
Share Issued
0.37
Ordinary Shares Number
0.37
Treasury Shares Number
0.00
Additional Paid In Capital
183.39
Retained Earnings
-174.36
Total Equity Gross Minority Interest
9.03
Total Capitalization
9.03
Working Capital
3.40
Invested Capital
9.03
Total Debt
3.68
Capital Lease Obligations
3.68
Net Tangible Assets
5.81
Tangible Book Value
5.81
Available For Sale Securities
0.70
Current Notes Payable
0.00
Inventories Adjustments Allowances
-0.13
Investmentin Financial Assets
0.70
Other Equity Interest
—
Preferred Shares Number
5.00
Preferred Stock Equity
0.01
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-1.45
-311.68%
-0.35
+91.80%
-4.30
+71.26%
-14.97
Cash Flow From Continuing Operating Activities
-1.45
-311.68%
-0.35
+91.80%
-4.30
+71.25%
-14.97
Cash From Discontinued Operating Activities
—
0.00
-100.00%
0.00
—
Net Income From Continuing Operations
-2.04
+44.84%
-3.70
+83.87%
-22.94
+67.27%
-70.08
Depreciation Amortization Depletion
1.80
-1.35%
1.82
-37.82%
2.93
-1.44%
2.97
Depreciation
1.03
-8.20%
1.12
-26.66%
1.53
-26.60%
2.09
Amortization Cash Flow
0.77
+9.69%
0.70
-50.05%
1.40
+57.90%
0.88
Depreciation And Amortization
1.80
-1.35%
1.82
-37.82%
2.93
-1.44%
2.97
Amortization Of Intangibles
0.77
+9.69%
0.70
-50.05%
1.40
+57.90%
0.88
Other Non Cash Items
0.09
-86.06%
0.62
+434.90%
-0.19
+97.81%
-8.46
Stock Based Compensation
0.01
-16.44%
0.02
-95.07%
0.34
-63.09%
0.93
Asset Impairment Charge
0.75
-23.27%
0.98
-93.49%
14.98
-75.77%
61.83
Operating Gains Losses
—
—
—
-0.29
Gain Loss On Investment Securities
—
—
—
0.03
Unrealized Gain Loss On Investment Securities
-0.09
-120.33%
0.43
—
—
Gain Loss On Sale Of PPE
—
—
0.00
+100.00%
-0.32
Change In Working Capital
-1.97
-280.81%
-0.52
-190.66%
0.57
+120.58%
-2.77
Change In Receivables
-0.44
-347.14%
0.18
-36.13%
0.28
+324.90%
0.07
Changes In Account Receivables
-0.44
-347.14%
0.18
-36.13%
0.28
+324.90%
0.07
Change In Inventory
-0.73
-195.62%
0.77
+2692.96%
0.03
+124.46%
-0.11
Change In Prepaid Assets
0.07
-85.83%
0.50
-80.40%
2.53
+7036.63%
0.04
Change In Payables And Accrued Expense
-0.26
+76.70%
-1.12
+12.87%
-1.29
+28.82%
-1.81
Change In Other Working Capital
0.00
-99.03%
0.32
+56.39%
0.20
+0.00%
0.20
Change In Other Current Liabilities
-0.61
+47.16%
-1.15
+2.32%
-1.18
-2.39%
-1.15
Investing Cash Flow
-0.18
+36.50%
-0.29
-141.29%
0.70
+202.00%
-0.69
Cash Flow From Continuing Investing Activities
-0.18
+36.50%
-0.29
-141.29%
0.70
+202.00%
-0.69
Net PPE Purchase And Sale
-0.18
+3.08%
-0.19
+36.14%
-0.30
+56.79%
-0.69
Purchase Of PPE
-0.18
+3.08%
-0.19
+36.14%
-0.30
+56.79%
-0.69
Capital Expenditure
-0.18
+36.50%
-0.29
+2.53%
-0.30
+56.79%
-0.69
Net Investment Purchase And Sale
—
0.00
-100.00%
1.00
0.00
Purchase Of Investment
—
—
—
0.00
Sale Of Investment
—
0.00
-100.00%
1.00
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.10
0.00
0.00
Purchase Of Intangibles
0.00
+100.00%
-0.10
0.00
0.00
Financing Cash Flow
1.45
+11.39%
1.30
+198.09%
-1.32
+67.22%
-4.04
Cash Flow From Continuing Financing Activities
1.45
+11.39%
1.30
+198.09%
-1.32
+67.22%
-4.04
Net Issuance Payments Of Debt
0.00
-100.00%
1.25
+1040.81%
-0.13
-297.54%
-0.03
Net Long Term Debt Issuance
—
—
-0.13
-297.54%
-0.03
Net Short Term Debt Issuance
0.00
-100.00%
1.25
+1040.81%
-0.13
—
Net Common Stock Issuance
0.00
-100.00%
0.05
-97.98%
2.48
0.00
Cash Dividends Paid
—
0.00
+100.00%
-3.67
+8.33%
-4.00
Changes In Cash
-0.19
-129.22%
0.65
+113.30%
-4.92
+75.00%
-19.69
Beginning Cash Position
2.45
+36.42%
1.80
-73.25%
6.72
-74.56%
26.41
End Cash Position
2.26
-7.80%
2.45
+36.42%
1.80
-73.25%
6.72
Free Cash Flow
-1.64
-154.59%
-0.64
+86.02%
-4.60
+70.62%
-15.66
Interest Paid Supplemental Data
0.00
-100.00%
0.07
+1066.40%
0.01
+170.69%
0.00
Amortization Of Securities
—
—
0.00
-100.00%
0.91
Common Stock Issuance
0.00
-100.00%
0.05
-97.98%
2.48
0.00
Issuance Of Capital Stock
1.45
+2790.41%
0.05
-97.98%
2.48
0.00
Net Preferred Stock Issuance
1.45
0.00
—
0.00
Preferred Stock Dividend Paid
—
0.00
+100.00%
-3.67
+8.33%
-4.00
Preferred Stock Issuance
1.45
0.00
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category